What every patient should understand before starting tirzepatide — the boxed warning, who should not use it, what to watch for, and exactly what to do if something doesn’t feel right. In an emergency, always call 911 first.
Read the Safety InformationTirzepatide is a dual GIP and GLP-1 receptor agonist — a once-weekly injection given under the skin that works with your body’s own hormone signals to regulate appetite and blood sugar. Through the ILSA platform, tirzepatide is available only after an independent licensed provider reviews your health history and determines it is appropriate for you. If approved, it is prepared by a licensed U.S.-based 503A compounding pharmacy and shipped to your door.
This page summarizes important safety information. It does not replace the guidance of your provider or the instructions that come with your medication — always follow both, and ask your provider about anything you’re unsure of.
In studies with rodents, tirzepatide caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is not known whether tirzepatide causes thyroid C-cell tumors, including MTC, in people.
Do not use tirzepatide if you or any of your family have ever had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tell your provider right away if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Tirzepatide is not appropriate for everyone. Do not use it — and tell your provider during your assessment — if any of the following apply to you.
This list is not exhaustive. Your provider makes the final determination based on your complete health history — be thorough and honest in your intake.
These are the established risks of tirzepatide therapy. Your provider weighs each one against your health history before approving treatment — and monitors for them while you’re on it.
The most common side effects are digestive, tend to be strongest when starting or moving up a dose, and often ease as your body adjusts. Eating smaller meals, avoiding rich or greasy food, and staying hydrated all help.
This is not a complete list of side effects. Your pharmacy’s medication information sheet has the full details — read it before your first dose.
Tell your provider about every medication and supplement you take — prescription and over-the-counter. A few interactions matter in particular.
Tirzepatide may cause harm to an unborn baby, and losing weight offers no benefit during pregnancy. If you become pregnant while using tirzepatide, stop taking it and contact your provider right away.
It is not known whether tirzepatide passes into breast milk — it is not recommended while breastfeeding. And if you use oral birth control pills, remember the interaction above: use a non-oral or added barrier method for 4 weeks after starting and after each dose increase.
You are never on your own with this medication. For emergencies, call 911. For urgent but non-emergency concerns, contact the provider overseeing your care through the platform. And for anything else, we’re at [email protected].
Compounded medication disclosure: if approved, prescriptions are dispensed by U.S.-based 503A compounding pharmacies that are registered with the FDA and operate in compliance with United States Pharmacopeia standards. Compounded medications are not FDA-approved and have not undergone FDA evaluation for safety, effectiveness, or manufacturing consistency. ILSA Health does not manufacture, compound, or directly dispense medications. ILSA is a telehealth platform that connects individuals with independent licensed providers and licensed U.S.-based pharmacies; it does not itself practice medicine or prescribe. Individual responses to treatment vary and no specific results are guaranteed. This page is educational only and is not medical advice.
Questions About Safety?
The best safety decision is an informed one. Start the online assessment and an independent licensed provider will review your health history, answer your questions, and determine whether tirzepatide is appropriate for you.
Educational only — not medical advice. Tirzepatide is available only after review by an independent licensed provider, who determines whether it is appropriate based on your individual health history. Compounded medications are not FDA-approved. Individual responses vary and no specific results are guaranteed.

The health assessment offered through ILSA Health is designed for preliminary screening and educational purposes only. Completion of this questionnaire does not create a doctor–patient relationship.
All medical services, including clinical evaluations, treatment plans, and prescription decisions, are provided exclusively by independent U.S.-licensed healthcare providers. Providers exercise full medical judgment and determine eligibility based on individual clinical assessment and applicable state regulations.
If approved, prescriptions are dispensed by U.S.-based 503A compounding pharmacies that are registered with the FDA and operate in compliance with United States Pharmacopeia standards. Compounded medications are not FDA-approved and have not undergone FDA evaluation for safety, effectiveness, or manufacturing consistency.
Individual responses to treatment vary. No specific results are guaranteed.
ILSA Health does not manufacture, compound, or directly dispense medications. Product appearance, packaging, and labeling may vary from images shown on this website.
All trademarks and product names are the property of their respective owners.
GET SUPPORT
Email: [email protected]
Phone: 754 227 9 227
1600 S Dixie HWY, Suite 108,
Boca Raton FL 33432
© ILSA Health - 2026 All Rights Reserved
Clinic Designed By: Med Clinic Authority